Finnadvance is developing miniature chips for the pharmaceutical industry and for research. The chips mimic functions of a human organ and allow for more precise and expedient drug discovery. This lowers costs by reducing the need for animal studies. The chips are used to develop therapies for rare diseases and to develop personalized medicine.
Multispectral imaging, microfluidics, Biomaterials, microfabrication, organonchips, and disease modelling
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Finnadvance? We’re happy to assist you with our Startup Sourcing service.